Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis
The DOI matches its Crossref record; 94 of the 98 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We aimed to estimate pooled percentages of patients with adrenal insufficiency after treatment with corticosteroids for various conditions in a meta-analysis. Secondly, we aimed to stratify the results by route of administration, disease, treatment dose, and duration. METHODS: We searched seven electronic databases (PubMed, MEDLINE, EMBASE, COCHRANE, CENTRAL, Web of Science, and CINAHL/Academic Search Premier) in February 2014 to identify potentially relevant studies. Original articles testing adult corticosteroid users for adrenal insufficiency were eligible. RESULTS: We included 74 articles with a total of 3753 participants. Stratified by administration form, percentages of patients with adrenal insufficiency ranged from 4.2% for nasal administration (95% confidence interval [CI], 0.5-28.9) to 52.2% for intra-articular administration (95% CI, 40.5-63.6). Stratified by disease, percentages ranged from 6.8% for asthma with inhalation corticosteroids only (95% CI, 3.8-12.0) to 60.0% for hematological malignancies (95% CI, 38.0-78.6). The risk also varied according to dose from 2.4% (95% CI, 0.6-9.3) (low dose) to 21.5% (95% CI, 12.0-35.5) (high dose), and according to treatment duration from 1.4% (95% CI, 0.3-7.4) (<28 d) to 27.4% (95% CI, 17.7-39.8) (>1 year) in asthma patients. CONCLUSIONS: 1) Adrenal insufficiency after discontinuation of glucocorticoid occurs frequently; 2) there is no administration form, dosing, treatment duration, or underlying disease for which adrenal insufficiency can be excluded with certainty, although higher dose and longer use give the highest risk; 3) the threshold to test corticosteroid users for adrenal insufficiency should be low in clinical practice, especially for those patients with nonspecific symptoms after cessation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk also varied when stratified for the underlying disease and increased with higher dose (low dose 2.4% (95% CI 0.6-9.3) to high dose 21.5% (95% CI 12.0-35.5)) and longer treatment duration (1.4% (95% CI 0.3-7.4) (<28 days) to 27.4% (95% CI 17.7-39.8) (>1 year)) in patients with asthma.”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“A meta-analysis of the risk of developing biochemical glucocorticoid-induced adrenal insufficiency stratified by glucocorticoid route of administration showed pooled percentages of 4.2% (95% CI 0.5-28.9) for nasal administration, 48.7% (95% CI 36.9-60.6) for oral use, and 52.2% (95% CI 40.5-63.6) for intra-articular administration (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Of these 521 patients, 98 patients had biochemical evidence of adrenal insufficiency. Ten of them (10%) reported symptoms. However, 88 (90%) did not report any symptoms”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“In the above-mentioned meta-analysis, ten of the 74 included studies also assessed symptoms of adrenal insufficiency (although not systematically scored) in a total of 521 patients (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Broersen et al performed a meta-analysis on eleven out of seventeen studies re-testing patients for biochemical adrenal insufficiency for which results could be categorized in short-term (defined as less than 4 weeks) high-dose glucocorticoid therapy re-testing after 4 weeks (six studies), and long-term (>1 year) medium-dose glucocorticoid therapy re-testing after 6 months (five studies) (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
20 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Oelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260403 · Cited by 381
Distinguishing Case Series From Cohort Studies
Dekkers, O. M., Egger, M., Altman, D. G., & Vandenbroucke, J. P. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-1-201201030-00006 · Cited by 308
Self-citationSuppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment
Henzen, C., Suter, A., Lerch, E., Urbinelli, R., Schorno, X. H., & Briner, V. A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06290-x · Cited by 290
Greenberg, G., Feagan, B., Martin, F., Sutherland, L., Thomson, A., Williams, C., Nilsson, L., & Persson, T. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536887 · Cited by 288
Research works printed but not linked: 1
- Ruiz Munoz, 1988, Adrenocortical function and steroid doses in renal transplant patients, Dial Transplant, 17, 184
Cited by
Items 101–200 of 457
Adrenal Insufficiency in Children With Eosinophilic Esophagitis Treated With Topical Corticosteroids
Bose, P., Kumar, S., Nebesio, T. D., Li, C., Hon, E. C., Atkins, D., Furuta, G. T., & Gupta, S. K. (2020) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002537 · Cited by 27
Secondary adrenal insufficiency: Where is it hidden and what does it look like?
Guaraldi, F., Karamouzis, I., Berardelli, R., D'Angelo, V., Rampino, A., Zichi, C., Ghigo, E., & Giordano, R. (2016) · Frontiers of hormone research · doi:10.1159/000443915 · Cited by 22
Nachawi, N., Li, D., & Lansang, M. C. (2024) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.91a.23039 · Cited by 34
Rademaker, M., Agnew, K., Andrews, M., Baker, C., Foley, P. A., Gebauer, K., Gupta, M., Rubel, D. M., Somerville, C., Sullivan, J. R., et al. (2019) · Australasian Journal of Dermatology · doi:10.1111/ajd.13141 · Cited by 25
Broersen, L. H. A., Horváth–Puhó, E., Pereira, A. M., Erichsen, R., Dekkers, O. M., & Sørensen, H. T. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000136 · Cited by 24
Self-citationZeng, Q., Shi, X., Yang, J., Yang, M., Zhao, W. M., Zhao, X., Shi, J., & Zhou, H. (2019) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12960 · Cited by 24
Alahmadi, F., Peel, A. M., Keevil, B. G., Niven, R. M., & Fowler, S. J. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13787 · Cited by 23
Novel insights in endocrine and metabolic pathways in sepsis and gaps for future research
Téblick, A., Gunst, J., Langouche, L., & den Berghe, G. V. (2022) · Clinical Science · doi:10.1042/cs20211003 · Cited by 24
The Contribution of Oral and Inhaled Glucocorticoids to Adrenal Insufficiency in Asthma
Brennan, V., Martin‐Grace, J., Greene, G., Heverin, K., Mulvey, C., McCartan, T., Lombard, L., Walsh, J., MacHale, E., Srinivasan, S., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.05.031 · Cited by 22
Emerging nanoparticle platforms to improve the administration of glucocorticoids
Tessier, B., Tsapis, N., Fattal, E., & Moine, L. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.039 · Cited by 22
Rushworth, R. L., Chrisp, G. L., & Torpy, D. J. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0117 · Cited by 22
Valentin, A., Borresen, S. W., Rix, M., Elung‐Jensen, T., Sørensen, S. S., & Feldt‐Rasmussen, U. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz180 · Cited by 22
The management of glucocorticoid deficiency: Current and future perspectives
Dineen, R., Martin‐Grace, J., Thompson, C. J., & Sherlock, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.006 · Cited by 21
Management of Patients With Glucocorticoid-Related Diseases and COVID-19
Chifu, I. O., Detomas, M., Dischinger, U., Kimpel, O., Megerle, F., Hahner, S., Faßnacht, M., & Altieri, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.705214 · Cited by 23
Adrenocortical dysfunction in rheumatoid arthritis: Α narrative review and future directions
Filippa, M. G., Tektonidou, M. G., Mantzou, A., Kaltsas, G., Chrousos, G. P., Sfikakis, P. P., & Yavropoulou, M. P. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13635 · Cited by 21
Melani, A. S., Croce, S., Fabbri, G., Messina, M., & Bargagli, E. (2024) · Biomolecules · doi:10.3390/biom14020195 · Cited by 19
Güven, A. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2019.0220 · Cited by 20
Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis
Brucato, A. L., Wheeler, A., Luis, S. A., Abbate, A., Cremer, P. C., Zou, L., Insalaco, A., LeWinter, M. M., Lewis, B. S., Lin, D., et al. (2022) · Heart · doi:10.1136/heartjnl-2022-321328 · Cited by 20
Baek, J. H., Kim, S. K., Jung, J. H., Hahm, J. R., & Jung, J. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.1.153 · Cited by 19
Burden of Oral Corticosteroid Use in Severe Asthma: Challenges and Opportunities
Canonica, G. W., Porsbjerg, C. M., Price, D. B., Wechsler, M. E., Heaney, L. G., Hanania, N. A., Gall, R., Pandit‐Abid, N., Jacob-Nara, J. A., & Sacks, H. J. (2025) · Allergy · doi:10.1111/all.16569 · Cited by 20
Neurological Complications of Endocrine Emergencies
Cruz‐Flores, S. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01105-2 · Cited by 20
Diagnosis and Management of Adrenal Insufficiency and Adrenal Crisis in the Emergency Department
Lentz, S. A., Collier, K. C., Willis, G., & Long, B. (2022) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2022.06.005 · Cited by 23
Topical clobetasol treatment for oral lichen planus can cause adrenal insufficiency
Einarsdottir, M. J., Bankvall, M., Robledo‐Sierra, J., Rödström, P., Bergthorsdottir, R., Trimpou, P., Hasséus, B., & Ragnarsson, Ó. (2023) · Oral Diseases · doi:10.1111/odi.14588 · Cited by 19
Bertsias, G. K., Askanase, A., Doria, A., Saxena, A., & Vital, E. M. J. (2024) · Rheumatology · doi:10.1093/rheumatology/keae041 · Cited by 21
Espósito, M. C., Santos, A. L., Bonfílio, R., & Araújo, M. B. (2019) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2019.1581050 · Cited by 18
Raschi, E., Fusaroli, M., Massari, F., Mollica, V., Repaci, A., Ardizzoni, A., Poluzzi, E., Pagotto, U., & Di Dalmazi, G. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac359 · Cited by 17
Menzies-Gow, A. N., Gurnell, M., Heaney, L. G., Corren, J., Bel, E. H., Maspero, J. F., Harrison, T., Jackson, D. J., Price, D. B., Lugogo, N. L., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.03226-2021 · Cited by 18
A Case of Iatrogenic Cushing’s Syndrome following Use of an Over-the-Counter Arthritis Supplement
Dunn, C. T., Amaya, J., & Green, P. A. (2023) · Case Reports in Endocrinology · doi:10.1155/2023/4769258 · Cited by 23
Adrenal Failure: An Evidence-Based Diagnostic Approach
Shaikh, S., Nagendra, L., Shaikh, S. S., & Pappachan, J. M. (2023) · Diagnostics · doi:10.3390/diagnostics13101812 · Cited by 23
“TAI generally develops from the suppression of the hypothalamic–pituitary–adrenal (HPA) axis by the administration of supraphysiological doses of exogenous steroids over a prolonged period of time [21].”
BackgroundChacón, A. G. M., Wang, C., Waqar, D., Syeda, S. A., Kumar, R., & Meghana, D. R. (2023) · Cureus · doi:10.7759/cureus.38948 · Cited by 29
“Studies have shown that around half of the patients develop signs and symptoms of adrenal insufficiency during oral glucocorticoid treatments or shortly after withdrawal [18].”
BackgroundThe unresolved riddle of glucocorticoid withdrawal
Pérez, F. G., Marengo, A. P., & Artero, C. V. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0691-1 · Cited by 18
Kieffer, T. E. C., Chin, P. Y., Green, E. S., Moldenhauer, L. M., Prins, J. R., & Robertson, S. A. (2020) · Molecular Human Reproduction · doi:10.1093/molehr/gaaa019 · Cited by 17
Sivapalan, P., Bikov, A., & Jensen, J. S. (2021) · Diagnostics · doi:10.3390/diagnostics11020236 · Cited by 20
Téblick, A., Bruyn, L. D., Oudenhove, T. V., Perre, S. V., Pauwels, L., Derde, S., Langouche, L., & den Berghe, G. V. (2021) · Endocrinology · doi:10.1210/endocr/bqab222 · Cited by 21
Adrenal crises in adolescents and young adults
Rushworth, R. L., Chrisp, G. L., Bownes, S., Torpy, D. J., & Falhammar, H. (2022) · Endocrine · doi:10.1007/s12020-022-03070-3 · Cited by 19
Corticosteroid refractory sarcoidosis
Goldman, C., & Judson, M. A. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106081 · Cited by 18
Tomkins, M., Martin‐Grace, J., Kennedy, C., McEnroe, O., Heverin, K., Srinivasan, S., Little, D. M., Conlon, P. J., de Freitas, D. G., Denton, M., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac044 · Cited by 17
“We suggest that the risk of TAI correlates with both daily prednisolone dose and cumulative glucocorticoid exposure.”
InfluentialWangberg, H., Mortazavi, D., Kitsen, J., Sanni, A., Leibel, S. A., & Geng, B. (2022) · Allergy and Asthma Proceedings · doi:10.2500/aap.2022.43.220027 · Cited by 16
Real world evidence supports waking salivary cortisone as a screening test for adrenal insufficiency
Debono, M., Caunt, S., Elder, C. J., Fearnside, J., Lewis, J., Keevil, B. G., Dixon, S., & Ross, R. J. M. (2023) · Clinical Endocrinology · doi:10.1111/cen.14975 · Cited by 21
Ruyssen‐Witrand, A., Brusq, C., Masson, M., Bongard, V., Salliot, C., Poiroux, L., Nguyen, M., Roux, C. H., Richez, C., Saraux, A., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2024-226620 · Cited by 18
Chronic stress induced loudness hyperacusis, sound avoidance and auditory cortex hyperactivity
Manohar, S., Chen, G., Li, L., Liu, X., & Salvi, R. (2023) · Hearing Research · doi:10.1016/j.heares.2023.108726 · Cited by 20
The use of systemic corticosteroids in asthma management in Latin American countries
Maspero, J. F., Cruz, Ã. A., Beltrán, C. F. P., Alí-Munive, A., Montero-Arias, F., Pliego, R. H., & Farouk, H. (2023) · World Allergy Organization Journal · doi:10.1016/j.waojou.2023.100760 · Cited by 20
Ibrahim, A., Dahlqvist, P. M., Olsson, T., Lundgren, D. W., Werner, M., Suhr, O. B., & Karling, P. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17730748 · Cited by 15
Zhao, Z., Jia, Z., Foster, K. W., Wei, X., Qiao, F., Jiang, H., Jin, Y., Li, G., Chen, N., Zhao, G., et al. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102302 · Cited by 17
Glucocorticoid induced adrenal insufficiency
Garrahy, A., Tomlinson, J., & Pal, A. (2022) · BMJ · doi:10.1136/bmj-2021-065137 · Cited by 18
Nanzer, A. M., Chowdhury, A. B., Raheem, A., Roxas, C., FERNANDES, M. R., Thomson, L., Green, L., Dhariwal, J., d’Ancona, G., Kent, B. D., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02273-2019 · Cited by 17
COVID-19: A rethink of corticosteroid injection?
Little, C. D. J., Birks, M. E., Horwitz, M. D., Ng, C. Y., & Warwick, D. J. (2020) · Bone & Joint Open · doi:10.1302/2046-3758.16.bjo-2020-0050.r1 · Cited by 15
Chang, C. Y., Prabhakar, A. M., Staffa, S. J., Husseini, J. S., Kheterpal, A., Simeone, F. J., & Bredella, M. A. (2020) · Skeletal Radiology · doi:10.1007/s00256-020-03656-w · Cited by 14
Staby, I., Krogh, J., Klose, M., Bækdal, J. A., Feldt‐Rasmussen, U., Poulsgaard, L., Springborg, J. B., & Andreassen, M. (2021) · Endocrine Connections · doi:10.1530/ec-21-0155 · Cited by 16
Immune checkpoint inhibitor-induced hypophysitis: clinical and biochemical features
Esteves-Ferreira, S., & Rosinha, P. M. O. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04659-5 · Cited by 15
Two Sides of the Same Coin?—Treatment of Chronic Asthma in Children and Adults
Chung, L. P., & Paton, J. Y. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00062 · Cited by 14
Sampieri, G., Namavarian, A., Lee, J. W., Hamour, A. F., & Lee, J. M. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22863 · Cited by 15
Guaraldi, F., Gori, D., Calderoni, P., Castiello, E., Pratelli, L., Leporati, M., Arvat, E., & Battaglia, M. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01033-6 · Cited by 13
An Approach to Minimising Risk of Adrenal Insufficiency When Discontinuing Oral Glucocorticoids
Nicholas, M. N., Li, S. K., & Dytoc, M. T. (2017) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475417736278 · Cited by 15
Carmichael, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00010-6 · Cited by 14
Hedenmalm, K., Kurz, X., & Morales, D. R. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02650-z · Cited by 13
Arshad, M. F., Elder, C., Newell-Price, J., Ross, R., & Debono, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae059 · Cited by 12
Safe Use of Corticosteroids in Non-Infectious Uveitis
Belletti, M., Izquierdo-Escámez, R., Tornero, C., Olivas-Vergara, O., Peiteado, D., & Carreño, E. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s540821 · Cited by 17
“74,75 In the context of NIU, systemic corticosteroids are often used at doses exceeding 7.5 mg/day of prednisone for months, which is well within the range associated with hypothalamic-pituitary-adrenal axis suppression and subsequent adrenal insufficiency.”
InfluentialXu, X. P., Schaefer, C. P., Szende, Á., Genofre, E. H., Katial, R. K., & Chung, Y. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.23034 · Cited by 14
Long-Term Evaluation of Low-Dose Betamethasone for Ataxia Telangiectasia
Hasegawa, S., Kumada, S., Tanuma, N., Tsuji‐Hosokawa, A., Kashimada, A., Mizuno, T., Moriyama, K., Sugawara, Y., Shirai, I., Miyata, Y., et al. (2019) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.05.006 · Cited by 13
van Eeden, C., Osman, M. S., & Tervaert, J. W. C. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2116002 · Cited by 14
Domínguez‐Ortega, J., Romero, J. D., Muñoz, X., Marco, A., & Blanco‐Aparicio, M. (2022) · Open Respiratory Archives · doi:10.1016/j.opresp.2022.100202 · Cited by 15
Ghajar, L. D., Heickman, L. K. W., Conaway, M. R., & Rogol, A. D. (2019) · Clinical Pediatrics · doi:10.1177/0009922818825154 · Cited by 12
Savas, M., Wester, V. L., van der Voorn, B., Iyer, A. M., Koper, J. W., van den Akker, E. L. T., & van Rossum, E. F. C. (2021) · Neuroendocrinology · doi:10.1159/000513703 · Cited by 13
The Glucocorticoid Taper: A Primer for the Clinicians
Priya, G., Laway, B. A., Ayyagari, M., Gupta, M., Bhat, G. H. K., & Dutta, D. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_410_23 · Cited by 14
“[24] reported that 15% of patients on long‑term oral steroids had persistent AI 3 years after discontinuing GCs. GC tapering in such patients is more difficult and needs to be slower over a more protracted course.”
BackgroundInfluentialMohseni, M., van der Valk, E. S., den Hurk, M. J. B. V., Savas, M., Boon, M. R., & van Rossum, E. F. C. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf166 · Cited by 11
Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19
Sabbadin, C., Betterle, C., Scaroni, C. M., & Ceccato, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.805647 · Cited by 13
Barra, C. B., Fontes, M. J. F., Cintra, M. T. G., Cruz, R. C., Rocha, J. A. G., Guimarães, M. C. C., & Silva, I. N. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.10.899 · Cited by 14
Krzyżański, W., Milad, M. A., Jobe, A. H., Peppard, T., Bies, R. R., & Jusko, W. J. (2021) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-021-09755-y · Cited by 11
Adrenal Gland Irradiation Causes Fatigue Accompanied by Reactive Changes in Cortisol Levels
Huang, Y., Chi, C., Wu, P., Tai, H.-C., Chien, M.-N., & Chen, Y.-J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051214 · Cited by 14
Steroid-Induced Iatrogenic Adrenal Insufficiency in Children: A Literature Review
Akahoshi, S., & Hasegawa, Y. (2020) · Endocrines · doi:10.3390/endocrines1020012 · Cited by 10
Pius, G., Ngapout, O. D., Makowa, L. K., Mbang, A., Binda, V., Albane, E. A., Batibonak, C., & Um, S. S. N. (2022) · Archives of Pediatrics · doi:10.29011/2575-825x.100203 · Cited by 10
Galligan, A., Iravani, A., Lasocki, A., Wallace, R., Weppler, A. M., Sachithanandan, N., Chiang, C. Y., Colman, P. G., Wentworth, J. M., Spain, L. A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1295865 · Cited by 11
Corticosteroids in critically ill patients: A narrative review
Haan, B. J., Blackmon, S. N., Cobb, A., Cohen, H. E., DeVier, M., Perez, M. M., & Winslow, S. F. (2024) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2944 · Cited by 17
Oral Corticosteroids for Skin Disease in the Older Population: Minimizing Potential Adverse Effects
Sparling, K., & Butler, D. C. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01143-8 · Cited by 13
Ishiguro, Y., Ohmori, T., Umemura, K., & Iizuka, M. (2020) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13594 · Cited by 9
Torpy, D. J., & Lim, W. T. (2023) · The Medical Journal of Australia · doi:10.5694/mja2.52140 · Cited by 13
Besemer, F., Kramers, C., Brinkman, K., Hermus, A. R., van Herwaarden, A. E., & Burger, D. M. (2020) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-020-00995-5 · Cited by 10
Prolonged Steroid Dependence in Adult Patients With Glioma
Mantilla, E., Abramowitz, J. D., Dan, T., & Pan, E. (2020) · Anticancer Research · doi:10.21873/anticanres.14163 · Cited by 11
Topical and Systemic Corticosteroids
Kraft, M., Soost, S., & Worm, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-68617-2_92 · Cited by 10
Maggio, R., Messina, F., D’Arrigo, B., Maccagno, G., Lardo, P., Palmisano, C., Poggi, M., Monti, S., Matarazzo, I., Laghi, A., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873189 · Cited by 12
Smy, L., Shaw, K., Amstutz, U., Staub, M., Chaudhry, S. A., Smith, A., Carleton, B., & Koren, G. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.04.006 · Cited by 10
Glucocorticoid induced adrenal insufficiency in children: Morning cortisol values to avoid LDSST
Laulhé, M., Dumaine, C., Chevenne, D., Leye, F., Faye, A., Dozières‐Puyravel, B., Strullu, M., Viala, J., Hogan, J., Houdouin, V., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.981765 · Cited by 13
Liu, J., Desai, K. R., Teng, C., Sturm, D., Stockbower, G. E., Patadia, H., & Willey, V. J. (2025) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s506043 · Cited by 10
“26 The nonsteroidal topical agents, calcineurin and PDE-4 inhibitors, are associated with application site reactions, such as burning or stinging.”
Changes in Adrenal Function and Insufficiency Symptoms After Cessation of Prednisolone
Hansen, S. B., Dreyer, A. F., Jørgensen, N. T., Al-Jorani, H., Bislev, L. S., Boesen, V. B., Borresen, S. W., Christensen, L. L., Glintborg, D., Hauge, E., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.1029 · Cited by 14
Self-citationHu, X., Pan, L., Chen, H., Chen, L., Tang, Y., Lv, D., Li, C., Zhang, J., & Luo, S. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202501018 · Cited by 10
Pitzner‐Fabricius, A., Dall, C. H., Henriksen, M., Hansen, E., Toennesen, L. L., Hostrup, M., & Backer, V. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.04.013 · Cited by 13
Oyama, Y., Iwafuchi, Y., & Narita, I. (2021) · CEN Case Reports · doi:10.1007/s13730-021-00619-5 · Cited by 9
Romanò, N., Duncan, P., McClafferty, H., Nolan, O., Ding, Q., Homer, N., Tissier, P. L., Walker, B., Shipston, M., & Chambers, T. J. G. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13165 · Cited by 9
Corticosteroids in Pediatric Septic Shock Are Not Helpful
Zimmerman, J. J. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002980 · Cited by 9
Redefining the paradigm of atypical hypoadrenocorticism in dogs
Shiel, R. E., & Mooney, C. T. (2019) · Companion animal · doi:10.12968/coan.2019.24.3.132 · Cited by 9
Hair cortisol and inhaled corticosteroid use in asthmatic children
Baan, E. J., van den Akker, E. L. T., Engelkes, M., de Rijke, Y. B., de Jongste, J. C., Sturkenboom, M., Verhamme, K. M. C., & Janssens, H. M. (2019) · Pediatric Pulmonology · doi:10.1002/ppul.24551 · Cited by 10
Hypertension in Cushing’s Syndrome
Ceccato, F., Barbot, M., Scaroni, C. M., & Boscaro, M. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-45562-0_8 · Cited by 9
Sepsis in newborns (Draft federal guidelines)
Аleksаndrovich, Y. S., Balashova, E. N., Боронина, И. В., Zavyalova, A. N., Zolotareva, L. S., Иванов, Д. О., Кирилочев, О. К., Лисица, И. А., Makulova, A. I., Миронов, П. И., et al. (2024) · Pediatrician (St Petersburg) · doi:10.17816/ped1545-53 · Cited by 8
Khandelwal, P., Fish, J. D., Gorfinkel, L., Guilcher, G. M. T., Howell, J. C., Nishitani, M., Nuechterlein, B., Obeng, E. A., Shah, A. J., Cuvelier, G. D. E., et al. (2025) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2025.01.891 · Cited by 13
Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical Therapies
Gooderham, M., Hong, C.-H., Lynde, C. W., Papp, K. A., Yeung, J., Lui, H., Miller-Monthrope, Y., Ringuet, J., Turchin, I., & Prajapati, V. H. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01386-2 · Cited by 10
“AEs may include local cutaneous AEs, such as atrophy, striae, and hypopigmentation (more commonly in patients with darker skin tones), as well as rare systemic AEs, such as adrenal insufficiency (due to hypo‑ thalamic–pituitary–adrenal axis suppression) if sufficient systemic absorption occurs [28].”
Salivary Steroid Collection in Children Under Conditions Replicating Home Sampling
Tonge, J. J., Keevil, B. G., Craig, J. N., Whitaker, M. J., Ross, R. J. M., & Elder, C. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac419 · Cited by 9
Treating asthma in the time of COVID
Carr, T. F., Fajt, M. L., Kraft, M., Phipatanakul, W., Szefler, S. J., Zeki, A. A., Peden, D. B., & White, S. R. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.12.800 · Cited by 12
Thyroid, Gonadal and Adrenal Dysfunction in Kidney Transplant Recipients: A Review for the Clinician
Bilhă, Ş., Hogas, S. M., Hogas, M. M., Marcu, S., Leuștean, L., Ungureanu, M.-C., Brǎnişteanu, D. D. D., & Preda, C. (2023) · Biomolecules · doi:10.3390/biom13060920 · Cited by 14
Palmowski, A., Pankow, A., Terziyska, K., Nielsen, S. M., Christensen, R., Bliddal, H., Boyadzhieva, Z., & Buttgereit, F. (2023) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2023.152349 · Cited by 8
Metadata
- Authors
- Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- Aarhus University (DK)
- Corresponding author
- Dekkers, Olaf M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-06-01
- Volume
- 100
- Issue
- 6
- Pages
- 2171-2180
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2022140603
- Cited by
- 456
- References
- 98
- Citations by year
- 2026: 39 · 2025: 53 · 2024: 50 · 2023: 55 · 2022: 52 · 2021: 48 · 2020: 53 · 2019: 39 · 2018: 28 · 2017: 20 · 2016: 14 · 2015: 5
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- Novo Nordisk Fonden (NNF-13OC0007869)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- adrenal insufficiency, glucocorticoid-induced adrenal insufficiency, corticosteroid use, glucocorticoid dose, treatment duration, route of administration, intra-articular corticosteroids, inhaled corticosteroids, asthma, hematologic malignancies, adrenal function testing
- MeSH terms
- Adrenal Cortex Hormones, Adrenal Insufficiency, Adult, Dosage Forms, Dose-Response Relationship, Drug, Drug Administration Routes, Drug Administration Schedule, Humans, Inflammation, Neoplasms, Skin Diseases, Organ Transplantation, Transplantation Conditioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.